Abstract
While there have been more and more studies concerning mitogen-activated protein kinases (MAPKs) signaling pathways, which control many cellular complex programmes, such as cell proliferation, differentiation, cell death and embryogenesis. However, few studies are carried out about expression and activation of classical MAPKs, extracellular signal-regulated kinase1/2 (ERK1/2) in human esophageal cancer cell line. Therefore, in the present study, we investigated the expression and activation of ERK1/2 in human esophageal cancer cell line EC9706 and human normal esophageal epithelial cell line Heepic, which is as control. This study showed that ERK1/2 was transiently phosphorylated both in EC9706 and Heepic, the kinetics of which were slightly different. To further study the ERK/MAPK signaling pathway in EC9706 and Heepic cell line, U0126 a kind of specific inhibitor of MEK was used. This study showed that U0126 can block the phosphorylation of ERK1/2 in a short time, the complete inhibition concentration for EC9706 and Heepic cell line is 50 and 20 μM, respectively. Incidentally, to further investigate the different roles of ERK1 and ERK2, vector-based short hairpin interference vectors targeted on ERK1/2 was constructed. Moreover, the effective interference target sequence was screened out in a transient transfection manner. MTT experiment showed that ERK2 is more important than ERK1 in the proliferation of EC9706 cells.
Similar content being viewed by others
Abbreviations
- ESCC:
-
Esophageal squamous cell carcinoma
- MAPK:
-
Mitogen-activated protein kinase
- ERK:
-
Extracellular-signal regulated kinase
- SDS-PAGE:
-
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
- FBS:
-
Fetal bovine serum
- PVDF:
-
Polyvinylidene fluoride
- Heepic:
-
Human normal esophageal epithelial cell
- p-ERK1/2:
-
Phosphorylated ERK1/2
- MTT:
-
Methylthiazolyl blue tetrazolium
References
Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al (2005) Cancer statistics, 2005. Cancer J Clin 55:10–30
Lambert R, Hainaut P (2007) The multidisciplinary management of gastrointestical cancer. Epidemiology of oesophagogastric cancer. Best Pract Res Clin Gasroenterol 21:921–945
Wang N, Dong XJ, Zhou RM, Guo W, Zhang XJ, Li Y (2009) An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of high-incidence region in northern China. Mol Biol Rep 36:357–364
Li Y, Sun DL, Duan YN, Zhang XJ, Wang N, Zhou RM, Chen ZF, Wang SJ (2009) Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China. Mol Biol Rep 37:197–205
Wang L, Xue L, Yan H, Li J, Lu Y (2009) Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells. Mol Biol Rep (Epub ahead of print) PubMed PMID: 19649725
Chan JY, Li L, Miao J, Cai DQ, Lee KK, Chui YL (2010) Differential expression of a novel gene BRE (TNFRSF1A modulator/BRCC45) in response to stress and biological signals. Mol Biol Rep 37:363–368
Bessard A, Fremin C, Ezan F, Fautrel A, Gailhouste L, Baffet G (2008) RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo. Oncogene 27:5315–5325
Lee JT Jr, McCubrey JA (2002) The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 16:486–507
Lefloch R, Pouyssegur J, Lenormand P (2008) Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels. Mol Cell Biol 28:511–527
Lewis TS, Shapiro PS, Ahn NG (1998) Signal transduction through MAP kinase cascades. Adv Cancer Res 74:49–139
Balmanno K, Cook SJ (2009) Tumor cell survival signalling by the ERK1/2 pathway. Cell Death Diff 16:368–377
Fremin C, Ezan F, Boisselier P, Bessard A, Pages G, Pouyssegur J, Baffet G (2007) ERK2 but not ERK1 plays a key role in Hepatocyte replication: an RNAi-mediated ERK2 knockdown approach in wild-type and ERK1 null hepatocytes. Hepatology 45:1035–1045
Wiesenauer CA, Yip-Schneider MT, Wang Y, Max Schmidt C (2004) Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma. J Am Coll Surg 198:410–421
Zeng P, Wagoner HA, Pescovitz OH, Steinmetz R (2005) RNA interferece (RNAi) for extracellular signal-regulated kinase 1 (ERK1) alone is sufficient to suppress cell viability in ovarian cancer cells. Cancer Biol Ther 4:961–967
Liu X, Yan S, Zhou T, Terada Y, Erikson RL (2004) The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23:763–776
Lev DC, Kim LS, Melnikova V, Ruiz M, Ananthaswamy HN, Price JE (2004) Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells. Brit J Cancer 91:795–802
Shama J, Garcia-Medina R, Pouyssegur J, Vial E (2008) Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells. Biochem Bioph Res Co 372:845–849
Ballif BA, Blenis J (2001) Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Diff 12:397–408
Kamakura S, Moriguchi T, Nishid E, Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases (1999) Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 274:26563–26571
Carthew RW (2001) Gene silencing by double-stranded RNA. Curr Opin Cell Biol 13:244–248
Tuschl T (2002) Expanding small RNA interference. Nat Biotechnol 20:446–448
Tang F, Meng G, Yang H, Li C-J, Shi Y, Ding M, Shang K-G, Zhang B, Xue Y (2004) Stable suppression of gene expression in murine embryonic stem cells by RNAi directed from DNA vector-based short hairpin RNA. Stem Cell 22:93–99
Novrino G (2004) Involvement of the intracellular ion channel CLIC1 in microglia-mediated β-amyloid-induced neurotoxicity. J Neurosci 24:5322–5330
Daoud G, Amyot M, Rassart É, Masse A, Simoneau L, Lafond J (2005) ERK1/2 and p38 regulate trophoblasts differentiation in human term placenta. J Physiol 566:409–423
Acknowledgements
The project was supported by the National Natural Science Foundation (No. 30760223, 30860097) and the First Affiliated of Xinjiang Medical University Grant (No. 2008-YFY-01).
Author information
Authors and Affiliations
Corresponding author
Additional information
S.T. Zheng and Q. Huo contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zheng, ST., Huo, Q., Tuerxun, A. et al. The expression and activation of ERK/MAPK pathway in human esophageal cancer cell line EC9706. Mol Biol Rep 38, 865–872 (2011). https://doi.org/10.1007/s11033-010-0178-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-010-0178-z